Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PPIG | CTRPv2 | pan-cancer | AAC | 0.093 | 0.009 |
mRNA | C16orf52 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.009 |
mRNA | CYP2C9 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.009 |
mRNA | C16orf71 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.009 |
mRNA | ELMSAN1 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.009 |
mRNA | EIF1 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.009 |
mRNA | CR2 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.009 |
mRNA | MRPL23 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.009 |
mRNA | CPPED1 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.009 |
mRNA | ANPEP | CTRPv2 | pan-cancer | AAC | -0.088 | 0.009 |